Literature DB >> 3408928

Poor sulphoxidation ability in patients with food sensitivity.

G K Scadding1, R Ayesh, J Brostoff, S C Mitchell, R H Waring, R L Smith.   

Abstract

Patients with well defined reactions to foods were examined for their ability to carry out both sulphur and carbon oxidation reactions by using carbocisteine and debrisoquine as probe compounds. The proportion of poor sulphoxidisers (58 of 74) was significantly greater than that of a previously determined normal control population (67 of 200; p less than 0.005). The proportion of poor carbon oxidisers was not significantly different from the controls. Metabolic defects may play a part in the pathogenesis of adverse reactions to foods.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408928      PMCID: PMC1833819          DOI: 10.1136/bmj.297.6641.105

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.

Authors:  R H Waring; S C Mitchell; J O'Gorman; M Fraser
Journal:  Biochem Pharmacol       Date:  1986-09-15       Impact factor: 5.858

2.  Systemic allergic reactions to ingested antigens.

Authors:  T M Golbert; R Patterson; J J Pruzansky
Journal:  J Allergy       Date:  1969-08

3.  IgE complexes in food allergy.

Authors:  C Carini; J Brostoff; D G Wraith
Journal:  Ann Allergy       Date:  1987-08

4.  The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.

Authors:  H W Devonshire; I Kong; M Cooper; T P Sloan; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

5.  Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.

Authors:  A R Boobis; S Murray; G C Kahn; G M Robertz; D S Davies
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

6.  Food hypersensitivity.

Authors:  D D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  1984-06       Impact factor: 10.793

Review 7.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

8.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

9.  A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Authors:  D A Evans; A Mahgoub; T P Sloan; J R Idle; R L Smith
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

  9 in total
  7 in total

Review 1.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

2.  Polymorphisms in oxidative drug metabolism: relationship to food preference.

Authors:  M R Britto; H E McKean; G G Bruckner; P J Wedlund
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

3.  Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.

Authors:  P Emery; H Bradley; A Gough; V Arthur; R Jubb; R Waring
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

4.  Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Authors:  J Brockmöller; B Staffeldt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Thalidomide-induced neuropathy and genetic differences in drug metabolism.

Authors:  C C Harland; G B Steventon; J R Marsden
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.

Authors:  P Seideman; R Ayesh
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 7.  Food allergy--fact or fiction: a review.

Authors:  R Finn
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.